Compare TEVA & HPQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | HPQ |
|---|---|---|
| Founded | 1901 | 1939 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 22.9B |
| IPO Year | N/A | N/A |
| Metric | TEVA | HPQ |
|---|---|---|
| Price | $28.43 | $25.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 13 |
| Target Price | ★ $27.00 | $25.85 |
| AVG Volume (30 Days) | 11.4M | ★ 13.9M |
| Earning Date | 11-05-2025 | 11-25-2025 |
| Dividend Yield | N/A | ★ 4.63% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.62 | ★ 2.65 |
| Revenue | $16,776,000,000.00 | ★ $55,295,000,000.00 |
| Revenue This Year | $4.74 | $2.73 |
| Revenue Next Year | $0.48 | $1.39 |
| P/E Ratio | $46.12 | ★ $9.78 |
| Revenue Growth | 0.02 | ★ 3.24 |
| 52 Week Low | $12.47 | $21.21 |
| 52 Week High | $28.68 | $36.81 |
| Indicator | TEVA | HPQ |
|---|---|---|
| Relative Strength Index (RSI) | 80.93 | 55.97 |
| Support Level | $24.01 | $23.50 |
| Resistance Level | $26.96 | $25.05 |
| Average True Range (ATR) | 0.68 | 0.77 |
| MACD | 0.19 | 0.34 |
| Stochastic Oscillator | 94.65 | 94.83 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
HP (formerly Hewlett-Packard) is a behemoth in the PC and printing markets. It has focused on these markets since it exited IT infrastructure in 2015 with the split from Hewlett Packard Enterprise. HP focuses on the commercial market, but maintains sales of consumer devices and printers. The firm has a broad and global customer base, with only one third of sales coming from the US. HP completely outsources manufacturing and relies heavily on channel partners for its sales and marketing.